Ritu Baral has a been a Senior Biotechnology Equity Research Analyst for 4 years, with a total of 7 years experience in biotechnology equity research. Her coverage focuses on orphan drugs, CNS, anti-infectives and cardiovascular companies. She first joined Canaccord as Senior Research Associate in Biotechnology in August 2007. Previously, Ritu was biotechnology equity research associate at JMP Securities and before that a research associate at Columbia University's Department of Medicine where she participated in neuroendocrine research focused on appetite and metabolism regulation, and completed graduate coursework in Immunology. Ritu graduated with a B.A. in Biological Sciences from Barnard College.